Hacking Your ADHD Research Recap with Skye: The Atomoxetine Trial
24 snips
Feb 13, 2026 
Skye Waterson, organizer and ADHD coach with Unconventional Organization, breaks down a randomized fMRI trial of atomoxetine. She explains default mode vs task-positive networks and how the drug shifted their balance. Conversation covers study design, participant details, key results on reduced default-mode activity, and practical tactics like stimulation, fidgets, and environment tweaks.
AI Snips
Chapters
Transcript
Episode notes
ADHD Alters The DMN–Task Network See-Saw
- The default mode network (DMN) activates during rest and daydreaming while the task-positive network activates during focused external tasks.
- Skye Waterson and William Curb explain ADHD shows a weaker push-pull anti-correlation between these networks compared to neurotypical brains.
Atomoxetine Changes Network Interactions
- A randomized double-blind placebo-controlled fMRI trial showed atomoxetine strengthens the anti-correlation between networks in medication-naive adults with ADHD.
- The study provides causal evidence that brain network differences in ADHD relate to symptoms and can be pharmacologically modified.
Brain Evidence Counters Stigma
- Showing brain differences in ADHD via rigorous studies reduces the stigma of 'just bad habits' by demonstrating biological mechanisms.
- Those findings empower tailored interventions and validate the need for different supports.